LMWH vs UFH | No demonstrated result suggested All cause death by 150% (not demonstrated) | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
Symptomatic deep-vein thrombosis | no data | Symptomatic pulmonary embolism | no data | Deep vein thrombosis | 1.07 [0.31 3.66] | p=1.00 | 0 | -36 | 2 | Harenberg,Harenberg, | proximal deep-vein thrombosis | no data | Venous thromboembolism or death | no data | asymptomatic DVT | no data | pulmonary embolism (symptomatic and asymptomatic) | no data | fatal pulmonary embolism | no data | Venous thromboembolism | no data | All cause death | 2.50 [1.22 5.15] | p=0.04 | 0 | -36 | 2 | Harenberg,Harenberg, | Major bleeding | no data | net benefit | no data | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |